Dr. Reddy's Laboratories Limited RDY
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -6.73% | -1.06% | 6.73% | 10.65% | 13.14% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -6.73% | -1.06% | 6.73% | 10.65% | 13.14% |
| Cost of Revenue | 9.55% | 12.43% | 17.52% | 18.37% | 16.98% |
| Gross Profit | -18.67% | -10.62% | -0.68% | 5.35% | 10.48% |
| SG&A Expenses | 6.64% | 8.83% | 9.97% | 12.88% | 15.45% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 24.99% | 4.54% | -59.93% | -48.81% | -53.93% |
| Total Operating Expenses | 5.90% | 8.24% | 11.48% | 13.85% | 15.46% |
| Operating Income | -52.98% | -33.78% | -9.75% | -0.28% | 5.38% |
| Income Before Tax | -48.77% | -30.87% | -3.63% | 2.27% | 4.11% |
| Income Tax Expenses | -58.13% | -38.68% | -11.90% | -3.68% | 15.08% |
| Earnings from Continuing Operations | -45.57% | -28.20% | -0.85% | 4.25% | 0.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 158.23% | 152.04% | 156.51% | 139.22% | -- |
| Net Income | -44.31% | -26.64% | 1.37% | 6.56% | -0.29% |
| EBIT | -52.98% | -33.78% | -9.75% | -0.28% | 5.38% |
| EBITDA | -41.16% | -25.08% | -5.03% | 3.65% | 7.49% |
| EPS Basic | -44.31% | -26.59% | 1.40% | 6.56% | -0.34% |
| Normalized Basic EPS | -49.47% | -30.03% | -2.55% | 3.83% | 5.68% |
| EPS Diluted | -44.26% | -26.54% | 1.46% | 6.58% | -0.31% |
| Normalized Diluted EPS | -49.41% | -29.97% | -2.46% | 3.91% | 5.72% |
| Average Basic Shares Outstanding | 0.03% | -0.03% | -0.03% | 0.01% | 0.05% |
| Average Diluted Shares Outstanding | -0.05% | -0.10% | -0.09% | -0.04% | 0.01% |
| Dividend Per Share | -5.41% | -5.41% | -4.05% | -4.05% | -4.05% |
| Payout Ratio | 0.72% | 0.31% | -0.05% | -0.10% | -0.01% |